![](https://biopharmanotes.com/wp-content/uploads/2021/07/featured-image-of-everolimus-326x245.png)
Everolimus Pharmacology
Everolimus is macrolide derivative and belongs to class of mTOR (mammalian target of Rapamycin) inhibitor. Its indication includes immunosuppressant and oncological indications. It is derivative […]
Everolimus is macrolide derivative and belongs to class of mTOR (mammalian target of Rapamycin) inhibitor. Its indication includes immunosuppressant and oncological indications. It is derivative […]
Copyright © 2024 | WordPress Theme by MH Themes